tiprankstipranks
Bio-UV Group SA (FR:ALTUV)
:ALTUV
France Market
Want to see FR:ALTUV full AI Analyst Report?

Bio-UV Group SA (ALTUV) AI Stock Analysis

0 Followers

Top Page

FR:ALTUV

Bio-UV Group SA

(ALTUV)

Select Model
Select Model
Select Model
Neutral 57 (OpenAI - 5.2)
Rating:57Neutral
Price Target:
€1.50
▼(-5.06% Downside)
Action:Reiterated
Date:05/09/26
The score is mainly supported by comparatively stronger cash generation and a reasonably stable balance sheet, but capped by declining revenue and inconsistent profitability. Technical indicators are largely neutral-to-soft (flat moving averages, slightly negative MACD, low stochastic), and valuation is difficult to justify using a negative P/E with no dividend yield provided.
Positive Factors
Cash generation
Consistent positive operating cash flow and accelerating free cash flow in 2025 improve financial flexibility. Durable cash conversion supports reinvestment in product development, funds working capital for project execution, and reduces dependence on external financing during cyclical revenue periods.
Negative Factors
Declining revenue trend
Sustained revenue declines from 2023–2025 limit operating leverage and constrain the company's ability to scale fixed-cost investments. Lower top-line pressure reduces margin expansion potential, weakens negotiating power with suppliers, and makes consistent earnings recovery harder without market share gains.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash generation
Consistent positive operating cash flow and accelerating free cash flow in 2025 improve financial flexibility. Durable cash conversion supports reinvestment in product development, funds working capital for project execution, and reduces dependence on external financing during cyclical revenue periods.
Read all positive factors

Bio-UV Group SA (ALTUV) vs. iShares MSCI France ETF (EWQ)

Bio-UV Group SA Business Overview & Revenue Model

Company Description
Bio-UV Group SA (ALTUV) specializes in the design and manufacturing of advanced disinfection systems utilizing ultraviolet (UV) technology. Operating primarily in the water treatment and sanitation sectors, the company offers a range of products t...
How the Company Makes Money
Bio-UV Group makes money primarily by selling water-treatment equipment, especially UV disinfection systems, to customers in its target end-markets. Its revenue model typically includes (1) product sales of UV reactors and complete treatment units...

Bio-UV Group SA Financial Statement Overview

Summary
Overall fundamentals are mixed. Cash flow is a clear positive (consistently positive operating cash flow and stronger free cash flow in 2025), and the balance sheet looks reasonably supported with manageable leverage and improved equity in 2025. Offsetting this, revenue has declined in recent years and profitability has been uneven, including volatility in gross profitability that reduces confidence in earnings quality.
Income Statement
52
Neutral
Balance Sheet
63
Positive
Cash Flow
72
Positive
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue35.90M39.58M43.13M51.29M33.46M
Gross Profit2.00M24.09M25.58M4.71M1.84M
EBITDA1.60M4.18M4.43M6.38M3.35M
Net Income836.34K31.36K124.89K2.42M689.38K
Balance Sheet
Total Assets69.21M66.09M71.41M74.08M81.12M
Cash, Cash Equivalents and Short-Term Investments10.18M3.87M2.73M1.98M10.57M
Total Debt20.23M23.99M28.27M29.15M30.74M
Total Liabilities28.68M33.40M39.19M41.74M50.43M
Stockholders Equity40.47M32.69M32.22M32.24M30.52M
Cash Flow
Free Cash Flow3.00M5.00M4.28M476.03K571.69K
Operating Cash Flow4.60M6.90M6.24M2.70M3.30M
Investing Cash Flow-1.60M-1.87M-1.95M-8.95M-20.70M
Financing Cash Flow3.40M-3.73M-3.57M-2.50M15.53M

Bio-UV Group SA Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1.58
Price Trends
50DMA
1.36
Positive
100DMA
1.37
Positive
200DMA
1.49
Negative
Market Momentum
MACD
0.01
Negative
RSI
54.96
Neutral
STOCH
67.52
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALTUV, the sentiment is Positive. The current price of 1.58 is above the 20-day moving average (MA) of 1.37, above the 50-day MA of 1.36, and above the 200-day MA of 1.49, indicating a neutral trend. The MACD of 0.01 indicates Negative momentum. The RSI at 54.96 is Neutral, neither overbought nor oversold. The STOCH value of 67.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:ALTUV.

Bio-UV Group SA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
64
Neutral
€1.52B12.4411.12%1.90%-2.88%24.39%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
61
Neutral
€25.56B20.8415.69%4.77%-0.66%9.47%
58
Neutral
€641.98M29.7612.51%1.69%5.24%-39.46%
57
Neutral
€19.43M21.78-9.27%1858.06%
42
Neutral
€15.05M-1.2622.45%103.54%-19.23%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FR:ALTUV
Bio-UV Group SA
1.40
-0.69
-32.85%
FR:DBG
Derichebourg
10.14
4.20
70.74%
FR:SCHP
Seche Environnement
82.90
-13.78
-14.25%
FR:VIE
Veolia Environnement
34.73
5.72
19.71%
FR:OREGE
Orege SA
0.29
0.04
15.35%
FR:GPE
Groupe Pizzorno Environnement SA
61.00
-2.44
-3.85%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 09, 2026